Sanofi, GSK launch trial for protein-based covid vaccine

PARIS : French drugmaker Sanofi and its British peer GSK have started a clinical trial for a protein-based COVID-19 vaccine candidate, as pharmaceutical companies race to develop treatments against the COVID-19 pandemic. Sanofi and GSK said on Thursday that they had started the...